- Home
- RLYB vs PODC Comparison
RLYB vs PODC Comparison
Compare RLYB & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLYB | PODC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6M | 59.2M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | RLYB | PODC |
|---|---|---|
| Price | $8.29 | $2.13 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 98.4K | 34.3K |
| Earning Date | 05-07-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $858,000.00 | N/A |
| Revenue This Year | N/A | $21.33 |
| Revenue Next Year | N/A | $19.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 43.00 | N/A |
| 52 Week Low | $0.22 | $1.30 |
| 52 Week High | $11.49 | $3.35 |
Technical Indicators
Market Signals| Indicator | RLYB | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 40.32 |
| Support Level | $7.90 | $1.89 |
| Resistance Level | $11.49 | $2.40 |
| Average True Range (ATR) | 0.57 | 0.16 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 20.62 | 17.77 |
Price Performance
Historical ComparisonAbout RLYB Rallybio Corporation
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.